Ingredient supplier Linnea has added its voice to the vinpocetine issue, submitting comments requesting the FDA to withdraw the tentative conclusion that vinpocetine cannot be used as a dietary ingredient.
Donald Trump’s historic victory leaves dietary supplement industry observers wrestling with the question of what will be the character of his administration, when the candidate himself has taken so many positions, some of which match standard conservative...
From market sizing to the positions from FDA and FTC on NDIs and claims substantiation, the International Probiotic Association’s DC workshop succeeded in providing a venue for sharing knowledge and expertise.
Dietary supplement champion Sen Orrin Hatch (R-UT) is calling for the withdrawal of a Federal Register Notice that questioned the regulatory status of vinpocetine as a new dietary ingredient.
The much anticipated Supplement OWL (Online Wellness Library) – a product label database – is moving into the second phase of beta-testing and is now accepting product labels from dietary supplement finished product manufacturers and marketers.
The Council for Responsible Nutrition has submitted comments to a Health Canada that urges the agency not to scrap the existing product registration system but rather to further refine it if that is deemed necessary and to better educate the public about...
The pace of Prop 65 suits in California continues to be brisk and settlement demands have been increasing, said a lawyer who represents dietary supplements in these actions.
A workshop hosted by the International Probiotics Association (IPA) in Washington, DC will tackle some of the key issues facing the probiotics sector, including positions from FDA and FTC on NDIs and claims substantiation.
The Food and Drug Administration should include colony forming units or CFUs for probiotic labeling, says Amy Smith from DuPont, with a citizen’s petition a possible avenue for the change.
Companies large and small have been beta-testing the CRN’s product registry – the Supplement Online Wellness Library (Supplement OWL) – and it will soon be open to all dietary supplement companies, but where are things right now and why should companies...
Under the combined pressure of industry and lawmakers, the federal Drug Enforcement Administration has backed off its emergency listing of kratom to the schedule 1 list of controlled substances.
The federal Drug Enforcement Administration's plan to move kratom to the Schedule 1 list via an emergency filing has spurred significant pushback from industry stakeholders and from lawmakers. But even within the herbal sphere not everyone agrees...
The Food and Drug Administration has extended the comment period on the updated draft version of the New Dietary Ingredients guidance. The new deadline for comments is Dec. 12.
Sharing of best practices, knowledge of cutting edge analytical techniques, current market data, and positions from FDA and FTC on NDIs and claims substantiation will be tackled at an upcoming workshop hosted by the International Probiotics Association.
The botanical ingredients raw material GMP program started by GNC and managed by the American Herbal Products Association will be ready for final review in October, said an AHPA official.
A recent FDA warning letter to a company selling noni products provides a quick précis for what not to do when trying to support your product with science, said an attorney who reviewed the communication.
More than half (56%) of dietary supplement professionals said they haven’t read the Aug. 11 NDI guidance—and 6% said they haven’t read it, but told their boss that they did.
Over the last few years, the FDA has zeroed in on the dietary supplement industry. It has taken numerous actions against dietary supplements where it believes the ingredients pose health risks to the public. This scrutiny continues with the release...
Wal-Mart Stores Inc. will remove the “Verified by an independent, certified laboratory” statement from its store-brand Spring Valley dietary supplement labels, following an agreement with Iowa’s Attorney General.
The Federal Trade Commission has taken action against the publisher of a large number of what it calls ‘predatory’ scientific journals. The complaint alleges the publisher lies about the journals’ quality and influence, and charges undisclosed fees.
There are increasing cases of malnutrition and nutrition deficiencies in a developed country like the US, recent studies report. We chat with an expert to get his analysis.
The updated New Dietary Ingredients draft guidance, issued yesterday by the Food and Drug Administration, modifies the agency’s stance on the contentious issue of synthetic, nature-identical compounds. But not by much.
The Natural Products Association has stepped up its campaign at the national level to blunt the effects of an administrative order in Puerto Rico that puts additional burdens on dietary supplement companies operating there.
The Natural Products Association (NPA) has announced the launch of its warning letter database, giving access to data on GMP violations, technical adulteration, and labeling infringements.
Nutrition giant Herbalife followed a winding road to the payment of a $200 million fine and an FTC-mandated restructuring. The network marketing company, with more than $4.5 billion revenue in 2015, can now move forward on its mission of business expansion...
The botanical raw material GMP proposal put forward by GNC earlier this year is in active revision, according the American Herbal Products Association.
A moribund Massachusetts bill that would have restricted the sale of certain dietary supplements is part and parcel of a rising tide of state bills that affect the industry, according to CRN.
Dietary supplement regulations are insufficient to adequately regulate the industry, according to a report about what was said at a meeting of six former FDA commissioners.
Is the dietary supplement industry getting a handle on the adulteration issue? The baseline data does not exist to be able to say one way or another. But sources agree that in the one thing you can measure—the attention the issue is getting—the situation...
The very nature of network marketing means companies selling dietary supplements using this model must be extra vigilant when it comes to compliance, an expert says.
Capstone Nutrition has sued MusclePharm for breach of contract, stating in its complaint that “MusclePharm has essentially turned Capstone into its bank.”
Industry stakeholders called Sen. Claire McCaskill’s recent call for FDA scrutiny of supplement interactions with chemotherapy treatments unnecessary and an intrusion on doctor/patient relationships.
Senator Claire McCaskill, the ranking member of the US Senate Special Committee on Aging, is seeking clarification about potential interactions between dietary supplements and chemotherapy treatments.
Transparency has become a watchword among dietary supplement companies. Jim Emme, president of NOW Foods, said it is one of the founding principles of his company.
The Council for Responsible Nutrition has filed comments with officials in California in an effort to blunt the effect of proposed changes to Prop 65 which could add new burdens for industry.
The Center for Science in the Public Interest has called on the Food and Drug Administration to ban the sale of high potency caffeine products to consumers. Despite FDA’s warning letters of last year, the products are still widely for sale, CSPI said.
The US Food and Drug Administration tells NutraIngredients-USA that it looks forward to learning more about the Council for Responsible Nutrition’s proposed industry-wide dietary supplement product registry.
Senator Claire McCaskill, the ranking member of the US Senate Special Committee on Aging, is alarmed that FDA has taken so long to act against manufacturers of supplements containing methylsynephrine / oxilofrine.
Some sports supplements formulated with the illegal ingredient methylsynephrine may contain doses above and beyond the pharmaceutical dosages, says a new study led by Dr Pieter Cohen.
The US Food and Drug Administration has issued warning letters to 7 companies regarding a total of 8 products marketed as dietary supplements and containing methylsynephrine as a dietary ingredient.
Senator Claire McCaskill, the ranking member of the US Senate Special Committee on Aging, is seeking a comprehensive list of enforcement actions taken by the Department of Justice related to the dietary supplement industry.
Scott Bass, partner, Sidley Austin LLP, and Steve Mister, President & CEO of the Council for Responsible Nutrition (CRN), will co-chair the Fourth Annual Legal, Regulatory, and Compliance Forum on Dietary Supplements.
Experts from the US FDA, EFSA, Food Standards Australia New Zealand, and Anvisa will provide regulatory insights about global probiotic regulations at the 2016 IPA World Congress + Probiota Americas.
The US Food and Drug Administration has issued five warning letters about products containing Acacia rigidula, which it considers a new dietary ingredient (NDI) lacking a successful NDI notification.
Former Sen. Tom Harkin has a message for the dietary supplements industry: Despite challenges from law enforcement officials, legislators and hostile media stories, the best days are ahead.
